Evidence map›Paper›PMID 41394294›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025

Correlation Between CD38

Yanan Wang, Weifang Mao, Lin Xu, Wenfang Xu

Abstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yanan WangClinical Laboratory, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, People's Republic of China.ORCID 0000-0002-9936-049X
Weifang MaoClinical Laboratory, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, People's Republic of China.
Lin XuClinical Laboratory, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, People's Republic of China.
Wenfang XuClinical Laboratory, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study aimed to investigate the association between CD38 Patients and Methods: Clinical data and lymphocyte subset profiles of 596 TB patients admitted to Affiliated Hospital of Shaoxing University from November 2022 to November 2024 were analyzed, including 115 DM-complicated and 481 non-DM cases. Logistic regression was used to evaluate the correlations between clinical indicators, lymphocyte subsets and PTB-DM. Generalized linear models were employed to assess the association of CD38 Results: The PTB-DM group exhibited a significantly higher prevalence of advanced age, male gender, and hypertension compared to the non-DM group ( Conclusion: CD38

Indexed as

CD38+ cellsdiabetes mellitusimmune regulationtuberculosis

Identifiers

PMID41394294
PMCPMC12695711

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.